Rapamycin reduces tau phosphorylation in primary rodent neurons [17] and in P301S mice [54, 55] and prevents the hyperphosphorylation of tau induced either by high glucose diet [56] or Aβ [57] in the 3XTg-AD mouse. Here, MAPT is linked to Alzheimer disease.